Novel cancer vaccines prepared by anchoring cytokines to tumor cells avoiding gene transfection

Philippe Nizard; David-Alexandre Gross; Alexandre Chenal; Bruno Beaumelle; Konstadinos Kosmatopoulos; Daniel Gillet

doi:10.1117/12.469781

4 June 2002 Novel cancer vaccines prepared by anchoring cytokines to tumor cells avoiding gene transfection

Philippe Nizard, David-Alexandre Gross, Alexandre Chenal, Bruno Beaumelle, Konstadinos Kosmatopoulos, Daniel Gillet

Proceedings Volume 4625, Clinical Diagnostic Systems: Technologies and Instrumentation; (2002) https://doi.org/10.1117/12.469781
Event: International Symposium on Biomedical Optics, 2002, San Jose, CA, United States

Abstract

Cytokines have a strong potential for triggering anticancer immunity if released in the tumor microenvironment. Successful vaccines have been engineered using tumor cells genetically modified to secrete the cytokines. Unfortunately, this approach remains difficult and hazardous to perform in the clinic. We describe a new way of combining cytokines with tumor cells to prepare anticancer vaccines. This consists in anchoring recombinant cytokines to the membrane of killed tumor cells. Attachment is mediated by a fragment of diphtheria toxin (T) genetically connected to the cytokine. It is triggered by an acid pH pulse. The method was applied to IL-2, a potent anti-tumor cytokine. IL-2 anchored to the surface of tumor cells by the T anchor retained its IL-2 activity and remained exposed several days. Interestingly, vaccination of mice with these modified tumor cells induced a protective anti-tumor immunity mediated by tumor-specific cytotoxic T lymphocytes. This procedure presents several advantages as compared to the conventional approaches based on the transfection of tumor cells with cytokine genes. It does not require the culture of tumor cells from the patients and eliminates the safety problems connected with viral vectors while allowing the control of the amount of cytokines delivered with the vaccine.

Citation Download Citation

Philippe Nizard, David-Alexandre Gross, Alexandre Chenal, Bruno Beaumelle, Konstadinos Kosmatopoulos, and Daniel Gillet "Novel cancer vaccines prepared by anchoring cytokines to tumor cells avoiding gene transfection", Proc. SPIE 4625, Clinical Diagnostic Systems: Technologies and Instrumentation, (4 June 2002); https://doi.org/10.1117/12.469781

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available